Skip to main content

Cancer Biomarkers

Support This Research
Learn More

What are Cancer Biomarkers?

Cancer biomarkers are vital biological molecules found in blood, other body fluids, or tissues that provide key insights into cancer. They can indicate the presence of cancer, predict how a patient might respond to treatment, or measure the effectiveness of therapies.

These biomarkers – such as proteins, DNA, or RNA – are produced either by cancer cells or by the body in response to cancer. At Topic of Cancer, our research focuses on understanding why some treatments work better for certain patients, using biomarkers to help personalise therapies and improve outcomes for everyone.

Tumour Markers

Tumour markers are substances produced either by cancer cells or by the body in response to the presence of cancer. These markers are often found at elevated levels in people with certain types of cancer and can be detected in blood, urine, or tissues. They play a critical role in cancer care, helping with diagnosis, monitoring treatment effectiveness, and sometimes even predicting outcomes.

Examples include:

CA-125

This marker is commonly elevated in ovarian cancer. It is often used to help diagnose or monitor the progression of the disease.

Prostate-Specific Antigen (PSA)

PSA is a marker used to screen for prostate cancer. Elevated PSA levels may indicate the presence of cancer or other prostate conditions.

Alpha-fetoprotein (AFP)

Often associated with liver cancer and germ cell tumours, AFP can be used to diagnose or monitor treatment response in these conditions.

Carcinoembryonic Antigen (CEA)

CEA is typically elevated in colorectal cancer and some other cancers, such as pancreatic, stomach, and lung cancers. It is often used to track disease progression or recurrence.

Genetic Markers

DNA changes indicating cancer susceptibility.

Key mutations include:

BRCA1 and BRCA2

Mutations increasing the risk of breast and ovarian cancer.

KRAS

Mutations that drive disease and influence treatment outcomes in pancreatic cancer.

Researcher testing substances in test tube.

Epigenetic Markers

Modifications affecting gene expression without altering the DNA sequence itself, potentially influencing cancer development.

Syringe being used by a researcher

Gene Expression Profiles

Patterns of gene activity that help classify tumours and predict prognosis or treatment response.

Uses of Cancer Biomarkers

1

Early Detection and Diagnosis

Some biomarkers can help detect cancer at an earlier stage, potentially improving prognosis.
2

Prognosis

Biomarkers can provide information about the likely course or outcome of cancer, helping to predict how aggressive the disease may be.
3

Treatment Selection

Biomarkers can help determine which treatments are likely to be effective for a particular cancer. For example, tumors with specific genetic alterations may respond better to targeted therapies.
4

Monitoring Treatment Response

Changes in biomarker levels can help assess how well a treatment is working or if the cancer is recurring.
5

Personalised Medicine

In modern oncology, biomarkers are crucial for tailoring treatment plans to individual patients based on the molecular characteristics of their tumors.

Understanding and utilising cancer biomarkers is an essential part of contemporary cancer diagnosis, treatment, and management. Researchers continue to discover and validate new biomarkers to improve cancer care further.
Join our fight

Donate Today!

For as little as the cost of a coffee each week, you can help us get one step closer to a cure. Every donation powers life-saving research and provides vital support for cancer patients. Together, we can make a real difference.

Make a Donation
Corporate Sponsorship

Our Partners

A huge thank you to the support our partners continue to give us.